Caricamento...

Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL

OBJECTIVE: To assess the relationship between treatment response, baseline biomarker levels, and atacicept exposure in patients with systemic lupus erythematosus (SLE) in the phase II/III APRIL‐SLE study. METHODS: We performed a post hoc analysis of patients who received placebo, atacicept 75 mg, or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Rheumatol
Autori principali: Gordon, Caroline, Wofsy, David, Wax, Stephen, Li, Yong, Pena Rossi, Claudia, Isenberg, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681010/
https://ncbi.nlm.nih.gov/pubmed/27390168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39809
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !